Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS).

被引：0

作者：

Martin Broto, Javier

Silva Moura, David

Ramos, Rafael

Braglia, Luca

Collini, Paola

Renne, Salvatore L.

Romagosa, Cleofe

Coindre, Jean Michel

Velasco, Valerie

Merlo, Domenico F.

Palmerini, Emanuela

Stacchiotti, Silvia

Quagliuolo, Vittorio

Lopez-Pousa, Antonio

Grignani, Giovanni

Blay, Jean-Yves

Brunello, Antonella

Picci, Piero

Casali, Paolo Giovanni

Gronchi, Alessandro

机构：

[1] Univ Seville, Virgen del Rocio Univ Hosp, Inst Biomed Res IBIS, CSIC, Seville, Spain

[2] Univ Seville, Inst Biomed Seville, Grp Adv Therapies & Biomarkers Sarcomas, Ibis,Hosp Univ Virgen Del Rocio,CSIC, Seville, Spain

[3] Hosp Univ Son Espases, Palma de Mallorca, Spain

[4] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Clin Trial Ctr, Genoa, Italy

[5] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Dept Epidemiol, Genoa, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Pathol & Lab Med, Soft Tissue & Bone Pathol Histopathol & Pediat Pa, Milan, Italy

[7] Humanitas Res Hosp, Anat Pathol Unit, Milan, Italy

[8] H Vall dHebron, Barcelona, Spain

[9] Inst Bergonie, Bordeaux, France

[10] Inst Bergonie, Dept Pathol, Bordeaux, France

[11] IRCCS Ist Ortoped Rizzoli, Bologna, Italy

[12] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[13] Ist Clin Humanitas, Milan, Italy

[14] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[15] FPO IRCCS, Candiolo Canc Inst, Div Med Oncol, Candiolo, TO, Italy

[16] UNICANCER, Ctr Leon Berard, Lyon, France

[17] Ist Oncol Veneto IRCCS, Med Oncol Unit 1, Clin & Expt Oncol Dept, Padua, Italy

[18] Italian Sarcoma Grp, Bologna, Italy

[19] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Mesenchymal & Rare Tumor Unit, Milan, Italy

[20] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Sarcoma Serv, Milan, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

基金：

欧洲研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1001

引用

页数：2

共 50 条

[1] Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial
Martin-Broto, Javier
Lopez-Alvarez, Maria
Moura, David S.
Ramos, Rafael
Collini, Paola
Romagosa, Cleofe
Bague, Silvia
Renne, Salvatore L.
Barisella, Marta
Velasco, Valerie
Coindre, Jean-Michel
Lopez-Lopez, Daniel
Dopazo, Joaquin
Gambarotti, Marco
Braglia, Luca
Merlo, Domenico Franco
Palmerini, Emanuela
Stacchiotti, Silvia
Quagliuolo, Vittorio L.
Lopez-Pousa, Antonio
Grignani, Giovanni
Blay, Jean-Yves
Brunello, Antonella
Gutierrez, Antonio
Valverde, Claudia
Hindi, Nadia
Dei Tos, Angelo Paolo
Picci, Piero
Casali, Paolo G.
Gronchi, Alessandro
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2539 - 2552
[2] A phase III randomized trial of neo-adjuvant chemotherapy in high-risk soft tissue sarcoma (ISG-STS 1001): Feasibility and activity of concurrent chemotherapy and radiation therapy
Palassini, Elena
Pizzamiglio, Sara
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Tendero, Oscar
Beveridge, Robbie
Pousa, Antonio Lopez
Ferraresi, Virginia
Lugowska, Iwona
Fontana, Valeria
Bianchi, Giuseppe
Stacchiotti, Silvia
Dei Tos, Angelo Paolo
Verderio, Paolo
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[3] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Pasquali, Sandro
Palmerini, Emanuela
Quagliuolo, Vittorio
Martin-Broto, Javier
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Tendero, Oscar
Diaz-Beveridge, Robert
Ferraresi, Virginia
Lugowska, Iwona
Infante, Gabriele
Braglia, Luca
Merlo, Domenico Franco
Fontana, Valeria
Marchesi, Emanuela
Donati, Davide Maria
Palassini, Elena
Bianchi, Giuseppe
Marrari, Andrea
Morosi, Carlo
Stacchiotti, Silvia
Bague, Silvia
Coindre, Jean Michel
Dei Tos, Angelo Paolo
Picci, Piero
Bruzzi, Paolo
Miceli, Rosalba
Casali, Paolo Giovanni
Gronchi, Alessandro
CANCER, 2022, 128 (01) : 85 - 93
[4] CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
Frezza, Anna Maria
Stacchiotti, Silvia
Chibon, Frederic
Coindre, Jean-Michelle
Italiano, Antoine
Romagnosa, Cleofe
Bague, Silvia
Dei Tos, Angelo Paolo
Braglia, Luca
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Pousa, Antonio Lopez
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Beveridge, Robert Diaz
Lugowska, Iwona
Lesluyes, Tom
Maestro, Roberta
Merlo, Franco Domenico
Casali, Paolo Giovanni
Gronchi, Alessandro
CANCER MEDICINE, 2023, 12 (02): : 1350 - 1357
[5] Immune contexture in high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 randomized trial.
Pasquali, Sandro
Castelli, Chiara
Collini, Paola
Barisella, Marta
Romagosa, Cleofe
Bague, Silvia
Coindre, Jean Michel
De Tos, Paolo
Braglia, Luca
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Blay, Jean-Yves
Beveridge, Robert Diaz
Merlo, Domenico F.
Stacchiotti, Silvia
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[6] Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial.
Stacchiotti, Silvia
Morosi, Carlo
Braglia, Luca
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Tendero, Oscar
Beveridge, Robert Diaz
Lugowska, Iwona
Fontana, Valeria
Marchesi, Emanuela
Palassini, Elena
Bruzzi, Paolo
Merlo, Franco Domenico
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[7] Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
Vanzulli, A.
Vigorito, R.
Buonomenna, C.
Palmerini, E.
Quagliuolo, V.
Broto, J. M.
Pousa, A. Lopez
Grignani, G.
Brunello, A.
Blay, J. -y.
Beveridge, R. Diaz
Ferraresi, V.
Lugowska, I.
Pizzamiglio, S.
Verderio, P.
Duroni, V.
Fontana, V.
Donati, D. M.
Palassini, E.
Bianchi, G.
Bertuzzi, A.
Buonadonna, A.
Pasquali, S.
Tos, A. P. Dei
Casali, P. G.
Morosi, C.
Stacchiotti, S.
Gronchi, A.
ESMO OPEN, 2025, 10 (03)
[8] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial (vol 8, pg 85, 2022)
Pasquali, S.
Palmerini, E.
Quagliuolo, V
CANCER, 2022, 128 (17) : 3265 - 3265
[9] The prognostic value of CINSARC in a randomised trial comparing histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001).
Pasquali, Sandro
Braglia, Luca
Chibon, Frederic
Coindre, Jean Michel
Italiano, Antoine
Romagosa, Cleofe
Bague, Silvia
Dei Tos, Angelo Paolo
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Beveridge, Robert Diaz
Stacchiotti, Silvia
Merlo, Domenico F.
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[10] MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study
Martin-Broto, Javier
Gutierrez, Antonio M.
Ramos, Rafael F.
Lopez-Guerrero, Jose A.
Ferrari, Stefano
Stacchiotti, Silvia
Picci, Piero
Calabuig, Silvia
Collini, Paola
Gambarotti, Marco
Bague, Silvia
Dei Tos, Angelo P.
Palassini, Elena
Luna, Pablo
Cruz, Josefina
Cubedo, Ricardo
Martinez-Trufero, Javier
Poveda, Andres
Casali, Paolo G.
Fernandez-Serra, Antonio
Lopez-Pousa, Antonio
Gronchi, Alessandro
MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 249 - 259

← 1 2 3 4 5 →